[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338606-105":59,"doc-detail-338606-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-genome-wide-association-study-identifies-eight-loci-associated-with-intraductal-papillary-mucinous-neoplasm-progression-toward-malignancy","A genome-wide association study identifies eight loci associated with intraductal papillary mucinous neoplasm progression toward malignancy","","Intraductal papillary mucinous neoplasms (IPMNs) are pancreatic cancer precursors, yet only a subset progress to malignancy. This study aimed to identify germline genetic variants linked to IPMN clinical progression by performing a first genome-wide association study (GWAS) and computing a polygenic hazard score (PHS) in 338 patients. A Cox analysis adjusted for sex, age, cyst size, and top principal components was used. Eight significant loci were found, and variants suggested an inflammatory-prone mechanism. The PHS showed strong risk association, and the results support genetics-based patient stratification.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-genome-wide-association-study-identifies-eight-loci-associated-with-intraductal-papillary-mucinous-neoplasm-progression-toward-malignancy/338606/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-genome-wide-association-study-identifies-eight-loci-associated-with-intraductal-papillary-mucinous-neoplasm-progression-toward-malignancy/338606.png","ImageObject",300,407,{"name":92,"@type":93},"Theodora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study’s main objective for IPMN patients?","Question",{"text":112,"@type":113},"To identify germline genetic variants associated with IPMN clinical progression by conducting a genome-wide association study (GWAS) and computing a polygenic hazard score (PHS).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the statistical analysis performed in this study?",{"text":117,"@type":113},"The population was divided into two subsets, and Cox analysis adjusted for sex, age, cyst size at diagnosis, and the top 10 principal components was conducted. A PHS was calculated using genotypes of common variants linked to progression.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the results show about genetic loci and inflammatory processes?",{"text":121,"@type":113},"Eight loci showed significant associations, with the strongest at 7q21.11-rs117620617. The identified variants were associated with inflammatory processes, suggesting an inflammatory-prone phenotype may promote progression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338606,1790173905,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","DOI: 10. 1002/cncr.35678  \nORIGINAL ARTICLE  \nA genome‐wide association study identifies eight loci associated with intraductal papillary mucinous neoplasm progression toward malignancy  \nManuel Gentiluomo PhD 1  | Chiara Corradi PhD1 | Laura Apadula MS2 | Annalisa Comandatore MD3 | Gaetano Lauri MD2 | Gemma Rossi MD2 | Giulia Peduzzi PhD1 | Stefano Crippa MD, PhD4,5 | Cosmeri Rizzato PhD 1 | Massimo Falconi MD, PhD4,5 | Paolo Giorgio Arcidiacono MD PhD2,4 |  \nLuca Morelli MD, PhD3 | Gabriele Capurso MD, PhD2,4 | Daniele Campa PhD1   \n1Department of Biology, University of Pisa, Pisa, Italy  \n2Pancreato‐Biliary Endoscopy and Endosonography Division, Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy  \n3General Surgery Unit, Cisanello Hospital, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy  \n4Vita‐Salute San Raffaele University, Milan, Italy  \n5Division of Pancreatic Surgery and Transplantation, Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy  \nCorrespondence  \nDaniele Campa, Department of Biology, University of Pisa; Via Derna 1, 56126 Pisa, Italy.  \nEmail: [daniele.campa@unipi.it](daniele.campa@unipi.it)  \nFunding information  \nAssociazione Italiana per la Ricerca sul Cancro, Grant/Award Numbers: IG 2019‐ID 23672, IG 2021 ID 26201  \nAbstract  \nBackground: Intraductal papillary mucinous neoplasms (IPMNs) are precursors to pancreatic cancer, but not all IPMNs progress to cancer. The objective of this study was to identify the germline genetic variants associated with IPMN clinical progression by conducting the first genome‐wide association study (GWAS) and computing a polygenic hazard score (PHS) in 338 patients with IPMN.  \nMethods: The study population was divided into two subsets, and a Cox analysis adjusted for sex, age, cyst size at diagnosis, and the top 10 principal components was performed. A PHS was calculated using the genotypes of common variants associated with IPMN progression identified.  \nResults: Eight loci with significant associations (p \u003C 5 􀀂 10−8) were identified, and the most significant was 7q21. 11‐rs117620617 (hazard ratio, 16. 35; 95% confidence interval, 6.93–38. 60; p = 1.80 􀀂 10−10). All variants were associated with inflammatory processes, suggesting that alleles that predispose to an inflammatory prone phenotype may promote progression. The PHS indicated a statistically significant association (hazard ratio, 18.05; 95% confidence interval, 7.96–45.80; p = 6.18 􀀂 10−11) with IPMN progression among individuals who had the highest number of effect alleles (fourth quartile) compared with those who had the lowest number (first quartile).  \nConclusions: The current results study advance the understanding of individual predisposition to IPMN progression and underscore the potential use of genetics in the stratification of patients who have IPMN.  \n\n| The first two authors contributed equally to this article as first co‐authors.\u003Cbr>The last two authors contributed equally to this article as last co‐authors. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.\u003Cbr>© 2024 The Author(s). Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society. |\n\nCancer. 2025;e35678.  \n[https://doi.org/10.1002/cncr.35678](https://doi.org/10.1002/cncr.35678)  \nwi[leyonlinelibrary.com/journal/cncr](leyonlinelibrary.com/journal/cncr)  \n1 of 12  \nKEYWORDS  \ngenome‐wide association study (GWAS), intraductal papillary mucinous neoplasms, pancreatic cancer, polygenic score, progression  \nINTRODUCTION  \nIntraductal papillary mucinous neoplasms (IPMNs), the most common pancreatic premalignant les","cbCailMg5t9D1cTI","https://ap.wps.com/l/cbCailMg5t9D1cTI","pdf",1170266,12,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Clinical context and surveillance\n## Germline variants and prior evidence\n## Rationale for a GWAS approach","[{\"question\":\"What was the study’s main objective for IPMN patients?\",\"answer\":\"To identify germline genetic variants associated with IPMN clinical progression by conducting a genome-wide association study (GWAS) and computing a polygenic hazard score (PHS).\"},{\"question\":\"How was the statistical analysis performed in this study?\",\"answer\":\"The population was divided into two subsets, and Cox analysis adjusted for sex, age, cyst size at diagnosis, and the top 10 principal components was conducted. A PHS was calculated using genotypes of common variants linked to progression.\"},{\"question\":\"What did the results show about genetic loci and inflammatory processes?\",\"answer\":\"Eight loci showed significant associations, with the strongest at 7q21.11-rs117620617. The identified variants were associated with inflammatory processes, suggesting an inflammatory-prone phenotype may promote progression.\"}]","A genome-wide association study identifies eight loci associated with intraductal papillary mucinous neoplasm progression toward malignancy | PDF",1790024462,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7464c9a63dd74930ed5de6f26dd2f8af.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/73514d4330785ab6d1eb04a20826acf0.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1f21ce0ac44e4dc5a292335f5c67026f.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a2f98241137f77537628b53385d3551c.webp",980,1287]